Summary
In 27 patients initially diagnosed as refractory anaemia (RA) or RA with sideroblasts (RA-S) according to the FAB-classification a number of clinical, morphological and cytogenetic parameters were correlated for prognostic significance. From these correlations it emerged that severe cytopenia is centrally positioned with regard to clinical course in RA and RA-S. Positive correlations were found to initial diagnosis, clonal cytogenetic abnormalities, progression to RA with an excess of blasts (RAEB) or acute myeloid leukaemia (AML), the percentage of bone marrow blast cells and prolonged half life for radioactively labeled iron. The degree of peripheral blood granulocytopenia, alone, was correlated to bone marrow hypoplasia. Moreover, the frequency of abnormal karyotypes was inversely correlated to bone marrow cellularity and proportional to the frequency of bone marrow blast cells. From these relationships it may be proposed that chromosome abnormalities are associated with prolonged blast cell generation times and inhibition of blast cell maturation resulting in reduced marrow cellularity and blast cell accumulation, and, in the peripheral blood, falling percentages of neutrophil granulocytes. With the blast cell accumulation the bone marrow cellularity again becomes hyperplastic and the preleukaemic condition is transformed into RAEB or AML.
Similar content being viewed by others
References
Alexanian R, Alfrey CP (1976) Erythrokinetics and androgens in bone marrow cancer. Cancer 38: 833–840
Anderson RL, Bagby GC (1982) The prognostic value of chromosome studies in patients with the preleukemic syndrome (hemopoietic dysplasia). Leukemia Res 6: 175–181
Bennett JM, Catovsky D, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199
Clemmesen L, Hansen MM, Mortensen L, Thiede T, Videbaek Aa (1981) The applicability of simple blood and bone marrow variables in the prediction of acute leukaemia in patients with acquired bi- or pancytopenia. Scand J Haematol 27: 193–200
Coiffier B, Adeline P, Viala JJ, Bryon PA, Fiere D, Gentilhomme O, Vuvan H (1983) Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients. Cancer 52: 83–90
Cook JD, Marsaglia G, Eschbach JW, Funk DD, Finch CA (1970) Ferrokinetics. A biologic model for plasma iron exchange in man. J Clin Invest 49: 197–205
Greenberg ML, Chanana AD, Cronkite EP, Giacomelli G, Rai KR, Schiffer LM, Stryckmans PA, Vincent PC (1972) The generation times of human leukemic myeloblasts. Lab Invest 26: 245–252
Greenberg PL, Mata B (1979) The preleukemic syndrome. Correlation of in vitro parameters of granulopoiesis with clinical features. Am J Med 66: 951–958
ISCN (1978) An international system for human cytogenetic nomenclature. Cytogenet Cell Genet 21: 309–404
Israel V, Jaquillat C, Chastang C, Weil M, deHeaulme M, Boiron M, Bernard J (1975) Données nouvelles sur les leucémies oligoblastique. Nouvelle Presse Medicale 4: 947–952
Kerndrup G, Pallesen G, Melsen F, Mosekilde L (1980) Histomorphometrical determination of bone marrow cellularity in iliac crest biopsies. Scand J Haematol 24: 110–114
Koeffler HP, Golde DW (1980) Human preleukemia. Ann Int Med 93: 347–353
Linman JW, Bagby GC (1976) The preleukemic syndrome. Clinical and laboratory features, natural course and management. Blood Cells 2: 11–31
Montecucco C, Riccardi A, Traversi E, Giordano P, Mazzini G, Ascari E (1983) Proliferative activity of bone marrow cells in dysmyelopoietic (preleukemic) syndromes. Cancer 52: 1190–1195
Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D (1985) Myelodysplastic syndromes. A scoring system with prognostic significance. Br J Haematol 59: 425–433
Nielsen BJ (1966) Ferrokinetiske undersøgelser over haemoglobinproduktionens størrelse (Thesis). Munksgaard, Copenhagen
Nowell PC, Finan J (1978) Chromosome studies in preleukemic states. IV. Myeloproliferative versus cytopenic disorders. Cancer 42: 54–61
Pedersen B (1975) Clonal evolution and progression in chronic myeloid leukaemia. Blood Cells 1: 227–234
Pedersen B, Kerndrup G (1985) Specific minor chromosome deletions consistently occurring in myelodysplastic syndromes. Cancer Genet Cytogenet (in press)
Sakurai M, Hayata I, Sandberg AA (1976) Prognostic value of chromosomal findings in Ph1-positive chronic myelocytic leukemia. Cancer Res 36: 313–318
The second international workshop on chromosomes in leukaemia. Cancer Genet Cytogenet 2: 89–113
Trichot G, de Wolf-Peeters C, Vlietnck R, Verwilghen RL (1984) Bone marrow histology in myelodysplastic syndromes. II. Prognostic significance of abnormal localization of immature precursors in MDS. Br J Haematol 58: 217–225
Verma DS, Spitzer G, Dicke KA, McCredie KB (1979) In vitro agar culture patterns in preleukemia and their clinical significance. Leukemia Res 3: 41–49
Weisdorf DJ, Oken MM, Johnson GJ, Rydell RE (1983) Chronic myelodysplastic syndrome. Short survival with or without evolution to acute leukaemia. Br J Haematol 55: 691–700
Yunis JJ (1981) New chromosome techniques in the study of human neoplasia. Human Pathol 12: 540–549
Author information
Authors and Affiliations
Additional information
This study was supported by Grant no. 3/83 from The Danish Cancer Society
Rights and permissions
About this article
Cite this article
Kerndrup, G., Pedersen, B., Ellegaard, J. et al. Prognostic significance of some clinical, morphological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts. Blut 52, 35–43 (1986). https://doi.org/10.1007/BF00320140
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320140